Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

计划入组 226 人 · 首次发布于 2008 年 2 月 4 日

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

计划入组 18 人 · 首次发布于 2005 年 9 月 20 日

Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma

计划入组 40 人 · 首次发布于 2005 年 9 月 20 日

177Lu-G250

G250-scFV-transduced autologous T-lymphocyte cell therapy (Daniel den Hoed Cancer Center)

Girentuximab

Radiopharmaceuticals Reshape Cancer Treatment Landscape: From Thyroid to Advanced Prostate Cancer

Pulnovo Medical Enrolls First U.S. Patients in PULSE-LHD IDE Trial of PADN for Pulmonary Hypertension Associated with Left Heart Disease

Cereno Scientific Secures SEK 250 Million in Debt Financing to Advance Clinical Programs